Nephrogenic Systemic Fibrosis on Mammography

National Kidney Disease Education Program. Available at: http://nkdep.nih.gov. Accessed on March 18, 2014. Modification of Diet in Renal Disease Study equation: GFR (mL/min/1.73m2) = 175 × (Scr)−1.154 × (Age)−0.203 × (0.742 if female) × (1.212 if African American). Thomsen, 2012, Six years after, Acta Radiologica, 53, 827, 10.1258/ar.2012.12a005 Cowper, 2000, Scleromyxoedema-like cutaneous diseases in renal-dialysis patients, Lancet, 356, 1000, 10.1016/S0140-6736(00)02694-5 Grobner, 2006, Gadolinium—A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?, Nephrol Dial Transplant, 21, 1104, 10.1093/ndt/gfk062 Broome, 2007, Gadodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned, Am J Roentgenol, 188, 586, 10.2214/AJR.06.1094 Abujudeh, 2009, Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: Case series of 36 patients, Radiology, 253, 81, 10.1148/radiol.2531082160 Bennett, 2012, Gadolinium-induced nephrogenic systemic fibrosis: The rise and fall of an iatrogenic disease, Clin Kidney J, 5, 82, 10.1093/ckj/sfr172 Besheli, 2014, Current status of nephrogenic systemic fibrosis, Clin Radiol Weller, 2013, Gadolinium and nephrogenic systemic fibrosis: An update, Pediatr Nephrol Thomsen, 2013, Nephrogenic systemic fibrosis and gadolinium-based contrast media: Updated ESUR Contrast Medium SafetyCommittee guidelines, Eur Radiol, 23, 307, 10.1007/s00330-012-2597-9 Madke B, Khopkar U. Nephrogenic systemic fibrosis. Indian Dermatol Online J. 2(2):51-6 [PMID: 23130224]. George, 2013, Chronic fibrosing conditions in abdominal imaging, Radiographics, 33, 1053, 10.1148/rg.334125081 Cowper SE. The International Center for Nephrogenic Systemic Fibrosis Research (ICNSFR). Available at: http://www.icnfdr.org. Accessed on March 21, 2014. Kintossou, 2007, Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis: Role of gadolinium?, Ann Dermatol Venereol, 134, 667, 10.1016/S0151-9638(07)91830-X Wahba, 2007, The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy—Report of two cases and review of the literature, Nephrol Dial Transplant, 22, 631, 10.1093/ndt/gfl600 Chung, 2004, Nephrogenic fibrosing dermopathy: Response to high-dose intravenous immunoglobulin, Braz J Dermatol, 150, 596, 10.1111/j.1365-2133.2003.05795.x de Souza Machado IgrejaI, 2012, Nephrogenic systemic fibrosis: Concepts and perspectives, An Bras Dermatol, 87 Yeh, 2013, What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: A multidisciplinary approach, Radiographics, 33, 2003, 10.1148/rg.337135503 Yamauchi, 2012, Inflammatory breast cancer: What we know and what we need to learn, Oncologist, 17, 891, 10.1634/theoncologist.2012-0039 Amet, 2014, Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: The Prospective Fibrose Nephrogénique Systémique study, Invest Radiol, 49, 109, 10.1097/RLI.0000000000000000 Altun, 2009, Nephrogenic systemic fibrosis: Change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy—report from two U.S. universities, Radiology, 253, 689, 10.1148/radiol.2533090649